Palvella Therapeutics
Wayne, Pennsylvania, United States · Biotechnology
Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Wayne, Pennsylvania, United States
- Employees
- 30
- Industries
- Biotechnology
- Status
- Private
- Website
- palvellatx
- Company page
Recent activity at Palvella Therapeutics
About Palvella Therapeutics: questions and answers
What does Palvella Therapeutics do?
Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare
Where is Palvella Therapeutics headquartered?
Palvella Therapeutics is headquartered in Wayne, Pennsylvania, United States.
How many employees does Palvella Therapeutics have?
Palvella Therapeutics has about 30 employees.
What is the latest news on Palvella Therapeutics?
On Sep 09, 2026, Palvella Therapeutics Appoints James Treat, M.D. as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy